BRPI0406824A - Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm - Google Patents

Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm

Info

Publication number
BRPI0406824A
BRPI0406824A BR0406824-6A BRPI0406824A BRPI0406824A BR PI0406824 A BRPI0406824 A BR PI0406824A BR PI0406824 A BRPI0406824 A BR PI0406824A BR PI0406824 A BRPI0406824 A BR PI0406824A
Authority
BR
Brazil
Prior art keywords
preparation
antibacterial
intermediates
pharmaceutical compositions
compositions containing
Prior art date
Application number
BR0406824-6A
Other languages
English (en)
Inventor
Toni-Jo Poel
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BRPI0406824A publication Critical patent/BRPI0406824A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"INDOLONAOXAZOLIDINONAS ANTIBACTERIANAS, INTERMEDIáRIOS PARA SEU PREPARO E COMPOSIçõES FARMACêUTICAS QUE AS CONTêM". A presente invenção proporciona agentes antibacterianos de fórmula (I) e intermediários para a sua preparação.
BR0406824-6A 2003-02-24 2004-02-12 Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm BRPI0406824A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44973403P 2003-02-24 2003-02-24
PCT/IB2004/000466 WO2004074282A1 (en) 2003-02-24 2004-02-12 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
BRPI0406824A true BRPI0406824A (pt) 2005-12-27

Family

ID=32908714

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406824-6A BRPI0406824A (pt) 2003-02-24 2004-02-12 Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm

Country Status (26)

Country Link
US (1) US7012088B2 (pt)
EP (1) EP1599470A1 (pt)
JP (1) JP3887396B2 (pt)
KR (1) KR100701226B1 (pt)
CN (1) CN100349892C (pt)
AP (1) AP2005003375A0 (pt)
AU (1) AU2004213246A1 (pt)
BR (1) BRPI0406824A (pt)
CA (1) CA2515984A1 (pt)
CO (1) CO5601039A2 (pt)
CR (1) CR7956A (pt)
EA (1) EA009725B1 (pt)
EC (1) ECSP055980A (pt)
GE (1) GEP20084306B (pt)
HR (1) HRP20050658A2 (pt)
IS (1) IS7883A (pt)
MA (1) MA27661A1 (pt)
MX (1) MXPA05008960A (pt)
NO (1) NO20052794L (pt)
OA (1) OA13032A (pt)
PL (1) PL377428A1 (pt)
RS (1) RS20050649A (pt)
TN (1) TNSN05202A1 (pt)
UA (1) UA80326C2 (pt)
WO (1) WO2004074282A1 (pt)
ZA (1) ZA200505225B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
EA200701895A1 (ru) * 2005-04-06 2008-04-28 ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи Оксиндол-оксазолидинон в качестве антибактериального агента
AU2006231919A1 (en) * 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
WO2007088478A1 (en) * 2006-02-01 2007-08-09 Pfizer Products Inc. Indazole oxazolidinones as antibacterial agents
EP2004640A1 (en) * 2006-02-08 2008-12-24 Pfizer Products Inc. Oxazolidinones containing oxindoles as antibacterial agents
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
FR2948940B1 (fr) * 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP5685384B2 (ja) * 2010-03-29 2015-03-18 公益財団法人相模中央化学研究所 ３，３−ジフルオロ−２，３−ジヒドロインドール−２−オン誘導体の製造方法
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
HUE034106T2 (en) * 2012-10-17 2018-01-29 Univ Okayama Compound, tautomer and geometric isomer thereof, compound, tautomer or salt of geometric isomer, process for preparing the compound, tautomer, isomer or salt, antimicrobial agent and anti-infectious drug
CN103193794B (zh) * 2013-04-12 2016-04-06 中国药科大学 一种异吲哚酮并异噁唑类稠环化合物及其合成方法
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
CN107151225B (zh) * 2017-06-30 2020-05-08 贵州大学 2-羟基吲哚类衍生物、其制备方法和用途
CN113773306B (zh) * 2021-10-29 2023-11-10 四川农业大学 3,3-二取代吲哚酮类化合物及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
ES2157934T3 (es) 1988-09-15 2001-09-01 Upjohn Co Fenil-5-beta-amidometiloxazolidin-2-onas sustituidas con nitrogeno en la posicion 3.
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
DE19514313A1 (de) * 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
HRP960159A2 (en) 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
DE19601627A1 (de) * 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
DE19604223A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
DE19805117A1 (de) 1998-02-09 1999-08-12 Bayer Ag Neue Oxazolidinone mit azolhaltigen Tricyclen
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
EP1082323A2 (en) 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9821938D0 (en) 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
WO2000029409A1 (de) 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue heterocyclyl-substituierte oxazolidon-derivate
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
PE20011124A1 (es) 2000-03-31 2001-10-28 Upjohn Co Nuevos agentes antibacterianos de benzosultam oxazolidinona
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US8048386B2 (en) 2002-02-25 2011-11-01 Cepheid Fluid processing and control
PE20030044A1 (es) 2000-11-17 2003-02-09 Upjohn Co Isoxazolinonas biciclicas de formula i
JP2005512975A (ja) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体

Also Published As

Publication number Publication date
PL377428A1 (pl) 2006-02-06
HRP20050658A2 (en) 2005-12-31
NO20052794L (no) 2005-11-01
CA2515984A1 (en) 2004-09-02
MA27661A1 (fr) 2005-12-01
OA13032A (en) 2006-11-10
ECSP055980A (es) 2006-01-16
KR20050102135A (ko) 2005-10-25
TNSN05202A1 (fr) 2007-06-11
CR7956A (es) 2005-12-01
JP2006515012A (ja) 2006-05-18
UA80326C2 (en) 2007-09-10
EA200501341A1 (ru) 2006-02-24
WO2004074282A1 (en) 2004-09-02
EA009725B1 (ru) 2008-02-28
CO5601039A2 (es) 2006-01-31
AP2005003375A0 (en) 2005-09-30
GEP20084306B (en) 2008-02-11
ZA200505225B (en) 2006-11-29
EP1599470A1 (en) 2005-11-30
JP3887396B2 (ja) 2007-02-28
HK1082253A1 (zh) 2006-06-02
IS7883A (is) 2005-06-09
US20040176610A1 (en) 2004-09-09
KR100701226B1 (ko) 2007-03-29
CN1742008A (zh) 2006-03-01
AU2004213246A1 (en) 2004-09-02
US7012088B2 (en) 2006-03-14
RS20050649A (sr) 2007-11-15
CN100349892C (zh) 2007-11-21
NO20052794D0 (no) 2005-06-09
MXPA05008960A (es) 2005-11-04

Similar Documents

Publication Publication Date Title
BRPI0408347A (pt) derivados de pirimidina
BR0112030A (pt) Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor
DOP2002000422A (es) Agentes antibacterianos.
BRPI0408561A (pt) métodos para manufatura de 2'-desoxi-59-l-nucleosìeos
BR0313420A (pt) Quinolonas microbicidas, suas composições e usos
BR0111667A (pt) Novos compostos
HN2006019068A (es) "sintesis de (r)-n-metilnaltrexona"
CY1111867T1 (el) Ενωση ενεργοποιησης ppar και φαρμακευτικη συνθεση που περιεχει αυτη
ATE433447T1 (de) Pyrimiidinverbindungen
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
BRPI0619153A8 (pt) derivados de 4-aminopirroltriazina substituída, e composição farmacêutica
BRPI0213063B8 (pt) composto antibiótico de ação dupla, sua composição farmacêutica e seu uso
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
UY27424A1 (es) Agentes antidiabéticos
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
BR0113590A (pt) 7-oxo-piridopirimidinas
CL2004000804A1 (es) Procedimiento de preparacion en una sola etapa de n-(n'-glicilo substituida)-2-cianopirrolidina.
BR0213481A (pt) Sondas
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
BR0111669A (pt) Novos compostos
AR027067A1 (es) Benzoilciclohexanodionas substituidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.